The type of feto‐placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedure
Prenatal Diagnosis2015Vol. 35(10), pp. 994–998
Citations Over TimeTop 1% of 2015 papers
Francesca Romana Grati, Komal Bajaj, Francesca Malvestiti, Cristina Agrati, Beatrice Grimi, Barbara Malvestiti, Eva Pompilii, Federico Maggi, Susan J. Gross, Giuseppe Simoni, José Carlos Ferreira
Abstract
In cases of high-risk cfDNA results for T21/T18, CVS (combining cytotrophoblast and mesenchyme analysis) can be considered, but with the caveat of 2-4% risk of an inconclusive result requiring further testing. In high-risk results for MX/T13, amniocentesis would appear to be the most appropriate follow-up diagnostic test, especially in the absence of sonographic findings.
Related Papers
- → Interleucinas na encefalopatia hipóxico-isquêmica(2003)14 cited
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)